Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Acura Pharmaceuticals Inc. (ACUR)

0.531   -0.009 (-1.67%) 01-19 08:39
Open: 0.531 Pre. Close: 0.54
High: 0.531 Low: 0.531
Volume: 915 Market Cap: 35M
Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was incorporated in 1935 and is based in Palatine, Illinois.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.53 - 0.534 0.534 - 0.537
Low: 0.523 - 0.527 0.527 - 0.53
Close: 0.525 - 0.531 0.531 - 0.536

Technical analysis

as of: 2022-01-19 8:18:57 AM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.65     One year: 0.70
Support: Support1: 0.49    Support2: 0.41
Resistance: Resistance1: 0.56    Resistance2: 0.60
Pivot: 0.53
Moving Average: MA(5): 0.53     MA(20): 0.53
MA(100): 0.54     MA(250): 0.48
MACD: MACD(12,26):     Signal(9):
Stochastic oscillator: %K(14,3): 40.00     %D(3): 40.71
RSI: RSI(14): 49.38
52-week: High: 0.75  Low: 0.19  Change(%): 152.9
Average Vol(K): 3-Month: 903  10-Days: 454

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ACUR has closed above bottom band by 49.3%. Bollinger Bands are 19.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 16 Aug 2021
Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results - GlobeNewswire

Mon, 14 Jun 2021
Acura Pharmaceuticals Announces Conversion of Debt - GlobeNewswire

Fri, 28 Feb 2020
Acura Pharmaceuticals Announces Third Quarter 2019 Financial Results - GlobeNewswire

Wed, 15 Nov 2017
ACUR Stock Forecast, Price & News (Acura Pharmaceuticals) - MarketBeat

Fri, 17 Mar 2017
Acura Pharmaceuticals and MainPointe Pharmaceuticals Announce Deal for Nexafed® Products - GlobeNewswire

Mon, 10 Dec 2012
Acura Pharmaceuticals Launches Next Generation Cold Medicine To Aid In The Fight Against Meth - Pharmaceutical Online

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  MUTUAL_FUND
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. (M) 65
Shares Float (M) 9
% Held by Insiders 18.56
% Held by Institutions 3.01
Shares Short (K) 90
Shares Short P. Month (K) 76

Stock Financials

EPS -0.029
EPS Est This Year -0.460
EPS Est Next Year 0.370
Book Value (p.s.)
Profit Margin -51.27
Operating Margin -49.35
Return on Assets (ttm) -38.4
Return on Equity (ttm)
Qtrly Rev. Growth -34.1
Gross Profit (p.s.) 0.028
Sales Per Share 0.035
EBITDA (p.s.) -0.016
Qtrly Earnings Growth
Operating Cash Flow (M) 0
Levered Free Cash Flow (M) 0

Stock Valuations

PE Ratio -18.31
PEG Ratio
Price to Book value
Price to Sales 15.36
Price to Cash Flow -87.28

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.